A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers
Novartis
Novartis
Chongqing Precision Biotech Co., Ltd
Quadriga Biosciences, Inc.
Xencor, Inc.
Augusta University
Abramson Cancer Center at Penn Medicine
Alaunos Therapeutics
National Institutes of Health Clinical Center (CC)